Insider Buying: Humana (NYSE:HUM) Insider Buys 810 Shares of Stock

Humana Inc. (NYSE:HUM) insider Sanjay Shetty purchased 810 shares of Humana stock in a transaction dated Monday, February 23rd. The shares were acquired at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the transaction, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Humana Stock Performance

Shares of NYSE HUM traded up $2.57 during mid-day trading on Wednesday, hitting $177.21. The stock had a trading volume of 908,774 shares, compared to its average volume of 2,258,833. The company has a 50 day moving average of $233.89 and a two-hundred day moving average of $257.59. Humana Inc. has a twelve month low of $169.61 and a twelve month high of $315.35. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00. The firm has a market cap of $21.37 billion, a PE ratio of 18.04, a PEG ratio of 1.94 and a beta of 0.44.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. Humana’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period last year, the firm posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a yield of 2.0%. Humana’s payout ratio is presently 36.05%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company cut their target price on shares of Humana from $290.00 to $206.00 and set an “equal weight” rating for the company in a report on Wednesday, February 18th. Truist Financial lowered their target price on shares of Humana from $285.00 to $200.00 and set a “hold” rating on the stock in a research note on Tuesday, February 17th. Morgan Stanley set a $146.00 price target on Humana in a research note on Thursday, February 12th. Leerink Partners lowered their price target on Humana from $267.00 to $185.00 and set a “market perform” rating on the stock in a research report on Thursday, February 12th. Finally, TD Cowen dropped their price objective on Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Seven analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $225.48.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after purchasing an additional 106,030 shares during the last quarter. Dodge & Cox raised its position in shares of Humana by 5.6% during the 2nd quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after buying an additional 597,705 shares during the period. Capital International Investors raised its position in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares during the period. State Street Corp lifted its holdings in Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after acquiring an additional 97,211 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after acquiring an additional 1,008,514 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.